Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $10.68 Analyst target: $21.71 Upside: 103.28%
Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company is headquartered in Carlsbad, California.
See the full interactive analysis & chart →Informational only — not investment advice.